Phoenix Clinical Research Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-06-2024
- Paid Up Capital ₹ 0.10 M
as on 28-06-2024
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -99.34%
(FY 2015)
- Profit 3.06%
(FY 2015)
- Ebitda 1.64%
(FY 2015)
- Net Worth -9.68%
(FY 2015)
- Total Assets -5.37%
(FY 2015)
About Phoenix Clinical Research Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Jandani, Shail Maru, Anish Maru, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110RJ2008PTC026965
- Company No.
026965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2008
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Phoenix Clinical Research Services?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Jandani  | Director | 31-Mar-2018 | Current |
| Shail Maru | Director | 10-Jul-2008 | Current |
| Anish Maru | Director | 10-Jul-2008 | Current |
| Sanjay Saxena | Director | 31-Mar-2018 | Current |
Financial Performance of Phoenix Clinical Research Services.
Phoenix Clinical Research Services Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 99.34% decrease. The company also saw a slight improvement in profitability, with a 3.06% increase in profit. The company's net worth dipped by a decrease of 9.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phoenix Clinical Research Services?
In 2017, Phoenix Clinical Research Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jaipur X-Lab India Private LimitedActive 15 years 11 daysManoj Jandani, Shail Maru and 2 more are mutual person
- Maru Healthcare Private LimitedActive 17 years 8 months
Manoj Jandani, Shail Maru and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phoenix Clinical Research Services?
Unlock and access historical data on people associated with Phoenix Clinical Research Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phoenix Clinical Research Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phoenix Clinical Research Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
